Lanticse, Saturnino A.

HRN: 12-17-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
CEFTRIAXONE 1G (VIAL)
11/21/2022
11/27/2022
IV
2g
Q 24H
Infected Wound, R Foot
Waiting Final Action 
11/21/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/21/2022
11/28/2022
IV
600mg
Q8H
Infected Wound, R Foot
Waiting Final Action 
11/29/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
11/29/2022
12/06/2022
TOPICAL
Apply Thinly
BID
Dm Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: